Associated factors | Odds ratio(AOR) | 95% confidence interval | Strength of association | Author, year of publication |
---|---|---|---|---|
Older age | 3.31 | 1.26, 8.70 | Strong and positive | Tsegaw et al. 2017 |
Age group of 41–64 years | 3.1 | 1.3, 7.4 | Strong and positive | Yitbarek et al. 2019 |
Older age of 50Â years or above | 4.25 | 1.05, 17.18 | Strong and positive | Mossie et al. 2014 |
Older individuals | 1.06 | 1.03, 1.08 | Weak and positive | Wubetu et al. 2021 |
Being older than 40Â years | 2.81 | 1.11, 7.15 | Moderate and positive | Salahuddin et al. 2020 |
No formal education | 4.29 | 2.62, 7.02 | Strong and positive | Tsegaw et al. 2017 |
Being illiterate | 5.16 | 2.20, 12.07 | Strong and positive | Araya et al. 2020 |
Having no education | 3.11 | 1.37, 7.04 | Strong and positive | Mossie et al. 2014 |
Having a primary-level education | 3.27 | 1.46, 7.29 | Strong and positive | Araya et al. 2020 |
Being married | 0.377 | 0.21, 0.67 | Weak and negative | Animut et al. 2019 |
Unemployment status | 3.18 | 1.75, 5.78 | Strong and positive | Animut et al. 2019 |
Low monthly income | 4.22 | 2.02, 8.81 | Strong and positive | Wubetu et al. 2021 |
Body mass index 16Â kg/m2 | 4.39 | 1.60, 12.02 | Strong and positive | Animut et al. 2019 |
Having poor social support | 3.65 | 1.86, 7.17 | Strong and positive | Wubetu et al. 2021 |
Poor medication adherence | 1.49 | 1.01, 2.18 | Weak and positive | Tsegaw et al. 2017 |
Being non-compliant with prescribed medications | 2.99 | 1.01, 8.87 | Moderate and positive | Salahuddin et al. 2020 |
Lifetime use of tobacco | 2.40 | 1.44, 4.01 | Moderate and positive | Araya et al. 2020 |
Khat chewing | 4.4 | 2.3, 8.3 | Strong and positive | Yitbarek et al. 2019 |
Substance use | 4.64 | 2.3, 9.36 | Strong and positive | Mossie et al. 2014 |
Having a history of recreational drug use | 13.67 | 6.42, 29.13 | Strong and positive | Salahuddin et al. 2020 |
CD4 count of 500 cells/dl or less | 2.37 | 1.52, 3.68 | Moderate and positive | Tsegaw et al. 2017 |
Having a CD4 count (cells/μl) ≤ 500 | 1.61 | 1.11, 2.39 | Weak and positive | Araya et al. 2020 |
Plasma HIV-1 RNA load between 1.7log10 and 3log10 copies/ml | 2.2 | 1.1, 4.3 | Moderate and positive | Yitbarek et al. 2019 |
≥ 3log10 copies/ml | 7.5 | 2.6, 21.5 | Strong and positive | Yitbarek et al. 2019 |
Impairment in the activity of daily living | 7.19 | 1.73, 21.83 | Strong and positive | Belete et al. 2017 |
Have no communication about safe sexual intercourse | 2.88 | 1.61, 5.16 | Moderate and positive | Wubetu et al. 2021 |
Having co-morbid opportunistic infection | 7.48 | 4.1, 13.64 | Strong and positive | Mossie et al. 2014 |
Having comorbid depression and anxiety | 5.51 | 1.81, 16.79 | Strong and positive | Wubetu et al. 2021 |
Higher duration of HIV illness | 1.01 | 1.001, 1.02 | Weak and positive | Wubetu et al. 2021 |
Late clinical stage of the illness | 4.2 | 1.19, 14.44 | Strong and positive | Belete et al. 2017 |
Advancing stages of the disease | 3.558 | 1.41, 9.01 | Strong and positive | Animut et al. 2019 |
Clinical stage III of the disease | 5.6 | 1.7, 19.2 | Strong and positive | Yitbarek et al. 2019 |